AnaptysBio to Present at the Wedbush PacGrow 2019 Healthcare Conference

NEXT STORY
TCR2 Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires
PREV STORY
Point-of-Care (POC) Diagnostics Market to Rise at 6.6% CAGR, Advanced Technological Innovations in Products to Boost Market, says Fortune Business Insights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Reports First Quarter 2019 Financial Results

author_avatar
NASDAQ Market News

PDS Biotechnology Announces Oncology Research and Development Day

author_avatar
NASDAQ Market News